Publications
5803 Results
- Journal / Conference
- Annals of Hematology 87(Suppl.1):S57-S59
- Year
- 2008
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0432
Phase II studies of different schedules and doses of the farnesyltransferase inhibitor tipifarnib (R11577, zarnestra) for patients age 70 or older with previously untreated acute myeloid leukemia (AML): North American Intergroup Study S0432.
- Journal / Conference
- Journal of Neurooncology 86:353-358
- Year
- 2008
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-9149
A Phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149) [PMID18175205]
- Journal / Conference
- International Journal of Radiation Oncology Biology Physics 72:S70
- Year
- 2008
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9304 (INT-0144)
Pelvic failure (PF) analysis in INT0144: evaluation of chemotherapy regimen, risk group stratification, and nodal count
- Journal / Conference
- Journal of the American Statistical Association 103(484):1392-1404
- Year
- 2008
- Research Committee(s)
- Cancer Control
- PMID
- PMID20526381
- PMC
- PMC2880822
- Study Number(s)
- SWOG-9217
Does finasteride affect the severity of prostate cancer? A causal sensitivity analysis
- Journal / Conference
- Journal of Urology 180:2453-2457
- Year
- 2008
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8794
The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation in those patients: data from SWOG 8794 [PMID18930488]
- Journal / Conference
- British Journal of Urology International 101(8):933-934
- Year
- 2008
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
The Prostate Cancer Prevention Trial and the future of chemoprevention. PMID: 18353157
- Journal / Conference
- Journal of Thoracic Oncology 3(9):1026-1031
- Year
- 2008
- Research Committee(s)
- Lung
- Study Number(s)
- S0341
Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2 [PMID18758306; PMC3523698]
- Journal / Conference
- Journal of the American Medical Association 299(21):2515-2523
- Year
- 2008
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- C89803
Association of family history with cancer recurrence and survival among patients with stage III colon cancer [PMID18523220; NIHMS277201]
- Journal / Conference
- Cancer Prevention Research 1(3):167-173
- Year
- 2008
- Research Committee(s)
- Cancer Control
- PMID
- PMID19138952
- PMC
- NIHMSID551895
- Study Number(s)
- SWOG-9217
Pathologic characteristics of cancers detected in the Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention
- Journal / Conference
- Cancer Prevention Research 1(3):174-181
- Year
- 2008
- Research Committee(s)
- Cancer Control
- PMID
- PMID: 19138953
- PMC
- PMC2844801
- Study Number(s)
- SWOG-9217